| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2144205 | Lung Cancer | 2006 | 7 Pages |
Abstract
GP provided a significantly higher response rate and a longer time to progression than EP and should be considered a standard treatment in advanced NSCLC in Korean population.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jee Hyun Kim, Si Young Kim, Kyung Hae Jung, Keunchil Park, Cheol Won Suh, Ho Young Lim, Yeul Hong Kim, Baek Yeol Ryoo, Eun Kyung Cho, Byung Joo Park, Dae Seog Heo,